These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 24026246

  • 1. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy.
    Berthoux F, Mariat C, Maillard N.
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv160-6. PubMed ID: 24026246
    [Abstract] [Full Text] [Related]

  • 2. Validation of the absolute renal risk of dialysis/death in adults with IgA nephropathy secondary to Henoch-Schönlein purpura: a monocentric cohort study.
    Mohey H, Laurent B, Mariat C, Berthoux F.
    BMC Nephrol; 2013 Aug 01; 14():169. PubMed ID: 23915019
    [Abstract] [Full Text] [Related]

  • 3. Impact of body mass index on progression of primary immunoglobulin a nephropathy.
    Nagaraju SP, Rangaswamy D, Mareddy AS, Prasad S, Kaza S, Shenoy S, Saraf K, Attur RP, Parthasarathy R, Kosuru S, Mateti UV, Guddattu V, Koulmane Laxminarayana SL.
    Saudi J Kidney Dis Transpl; 2018 Aug 01; 29(2):318-325. PubMed ID: 29657199
    [Abstract] [Full Text] [Related]

  • 4. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C, Wang AY, Li G, Wang L.
    BMC Nephrol; 2018 Dec 29; 19(1):381. PubMed ID: 30594167
    [Abstract] [Full Text] [Related]

  • 5. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.
    Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezène F, Berthoux F.
    Am J Kidney Dis; 2001 Apr 29; 37(4):720-7. PubMed ID: 11273871
    [Abstract] [Full Text] [Related]

  • 6. Predicting the risk for dialysis or death in IgA nephropathy.
    Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L.
    J Am Soc Nephrol; 2011 Apr 29; 22(4):752-61. PubMed ID: 21258035
    [Abstract] [Full Text] [Related]

  • 7. Association of obesity with the development of end stage renal disease in IgA nephropathy patients.
    Wang S, Qin A, Dong L, Tan J, Zhou X, Qin W.
    Front Endocrinol (Lausanne); 2023 Apr 29; 14():1094534. PubMed ID: 37020590
    [Abstract] [Full Text] [Related]

  • 8. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.
    Am J Nephrol; 2015 Apr 29; 41(3):210-9. PubMed ID: 25872002
    [Abstract] [Full Text] [Related]

  • 9. Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters.
    Kataoka H, Ohara M, Shibui K, Sato M, Suzuki T, Amemiya N, Watanabe Y, Honda K, Mochizuki T, Nitta K.
    Clin Exp Nephrol; 2012 Oct 29; 16(5):706-12. PubMed ID: 22350469
    [Abstract] [Full Text] [Related]

  • 10. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Oct 29; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 11. Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project.
    Shantsila A, Lane DA, Beevers DG, Lip GY.
    Hypertens Res; 2013 Jun 29; 36(6):546-9. PubMed ID: 23407241
    [Abstract] [Full Text] [Related]

  • 12. Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy.
    Ouyang Y, Xie J, Yang M, Zhang X, Ren H, Wang W, Chen N.
    PLoS One; 2016 Jun 29; 11(9):e0162044. PubMed ID: 27611091
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D, Liu J, Duan S, Chen P, Tang L, Zhang L, Feng Z, Cai G, Wu J, Chen X.
    Kidney Blood Press Res; 2018 Jun 29; 43(2):318-328. PubMed ID: 29529608
    [Abstract] [Full Text] [Related]

  • 14. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 29; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
    Liu Y, Ma X, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Am J Kidney Dis; 2014 Nov 29; 64(5):730-6. PubMed ID: 25134778
    [Abstract] [Full Text] [Related]

  • 16. Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service.
    Davis E, Campbell K, Gobe G, Hawley C, Isbel N, Johnson DW.
    BMC Nephrol; 2016 Jul 08; 17(1):74. PubMed ID: 27391644
    [Abstract] [Full Text] [Related]

  • 17. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D.
    Nephrol Dial Transplant; 2009 Sep 08; 24(9):2871-6. PubMed ID: 19369686
    [Abstract] [Full Text] [Related]

  • 18. Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy.
    Deng W, Tan X, Zhou Q, Ai Z, Liu W, Chen W, Yu X, Yang Q.
    BMC Nephrol; 2018 Feb 07; 19(1):31. PubMed ID: 29415664
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.
    Nephrology (Carlton); 2016 May 07; 21(5):387-96. PubMed ID: 26393772
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH.
    J Nephrol; 2016 Aug 07; 29(4):567-73. PubMed ID: 26537358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.